Tedizolid Phosphate

Name: Tedizolid Phosphate | 856867-55-5
Brand: US-CATO
SKU: S57C4X-10542_10_MG
Price: 19998.0 USD
Availability: OutOfStock

Cat. No S57C4X-10542_10_MG

Vendor: US-CATO

Product Information

Product Name

Tedizolid Phosphate

Brand Name

US-CATO

Product Number

C4X-10542

CAS

856867-55-5

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

11476460

IUPAC Name

(5R)-3-3-fluoro-4-6-(2-methyltetrazol-5-yl)-3-pyridinylphenyl-2-oxo-1,3-oxazolidin-5-ylmethyl dihydrogen phosphate

InChI Key

QCGUSIANLFXSGE-GFCCVEGCSA-N

SMILES

CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4CC@@H(OC4=O)COP(=O)(O)O)F

References Data Source From Pubchem

Tedizolid for osteoarticular infections: Evaluation of the published evidence

Publication Name: European Journal of Pharmacology

Publication Date: 2025-07-05

DOI: 10.1016/j.ejphar.2025.177458

A Phase 3 Study of the Safety and Efficacy of Tedizolid Phosphate in Patients <12 Years of Age With Acute Bacterial Skin and Skin Structure Infections

Publication Name: The Pediatric infectious disease journal

Publication Date: 2025-04-14

DOI: 10.1097/inf.0000000000004807

Pharmacokinetic/pharmacodynamic analysis of tedizolid phosphate against Staphylococcus aureus and Streptococcus pneumoniae in children, adolescents, and adults by Monte Carlo simulation

Publication Name: Journal of Global Antimicrobial Resistance

Publication Date: 2025-01

DOI: 10.1016/j.jgar.2024.11.011

Penetration of linezolid and tedizolid in cerebrospinal fluid of mouse and impact of blood–brain barrier disruption

Publication Name: Clinical and Translational Science

Publication Date: 2025-01

DOI: 10.1111/cts.70100

In vitro and in vivo evaluation of tedizolid nanoparticle incorporated buccal films for oromucosal infections

Publication Name: International Journal of Pharmaceutics

Publication Date: 2024-11-15

DOI: 10.1016/j.ijpharm.2024.124688

Tedizolid Phosphate

Product Information

General Information

References Data Source From Pubchem

Tedizolid for osteoarticular infections: Evaluation of the published evidence

A Phase 3 Study of the Safety and Efficacy of Tedizolid Phosphate in Patients <12 Years of Age With Acute Bacterial Skin and Skin Structure Infections

Pharmacokinetic/pharmacodynamic analysis of tedizolid phosphate against Staphylococcus aureus and Streptococcus pneumoniae in children, adolescents, and adults by Monte Carlo simulation

Penetration of linezolid and tedizolid in cerebrospinal fluid of mouse and impact of blood–brain barrier disruption

In vitro and in vivo evaluation of tedizolid nanoparticle incorporated buccal films for oromucosal infections